|
|
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2601-2609.
Prepublished online as a Blood First Edition Paper on December 18, 2003; DOI 10.1182/blood-2003-09-3319.
Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
GPIb-dependent platelet activation is dependent on Src kinases but not MAP kinase or cGMP-dependent kinase
Stuart J. Marshall,
Yotis A. Senis,
Jocelyn M. Auger,
Robert Feil,
Franz Hofmann,
Gary Salmon,
J. Thomas Peterson,
Frank Burslem, and
Steve P. Watson
From the Department of Pharmacology, University of Oxford, Oxford United Kingdom; Division of Medical Sciences, The Medical School, University of Birmingham, Edgbaston, Birmingham, United Kingdom; Institut für Pharmakologie und Toxikologie, Technische Universität (TU) München, München, Germany; Pfizer Global Research and Development, Sandwich, Kent, United Kingdom; and Cardiovascular Pharmacology, Pfizer Global Research and Development, Ann Arbor, MI.
Glycoprotein Ib-IX-V (GPIb-IX-V) mediates platelet tethering to von Willebrand factor (VWF), recruiting platelets into the thrombus, and activates integrin IIb 3 through a pathway that is dependent on Src kinases. In addition, recent reports indicate that activation of IIb 3 by VWF is dependent on protein kinase G (PKG) and mitogen-activated protein (MAP) kinases. The present study compares the importance of these signaling pathways in the activation of IIb 3 by GPIb-IX-V. In contrast to a recent report, VWF did not promote an increase in cyclic guanosine monophosphate (cGMP), while agents that elevate cGMP, such as the nitrous oxide (NO) donor glycoSNAP-1 (N-( -D-glucopyranosyl)-N2-acetyl-S-nitroso-D,L-penicillaminamide) or the type 5 phosphosdiesterase inhibitor, sildenafil, inhibited rather than promoted activation of IIb 3 by GPIb-IX-V and blocked aggregate formation on collagen at an intermediate rate of shear (800 s-1). Additionally, sildenafil increased blood flow in a rabbit model of thrombus formation in vivo. A novel inhibitor of the MAP kinase pathway, which is active in plasma, PD184161, had no effect on aggregate formation on collagen under flow conditions, whereas a novel inhibitor of Src kinases, which is also active in plasma, PD173952, blocked this response. These results demonstrate a critical role for Src kinases but not MAP kinases in VWF-dependent platelet activation and demonstrate an inhibitory role for cGMP-elevating agents in regulating this process.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Articles in Blood Online:
-
Does cGMP mediate platelet inhibition or stimulation?
- Wolfgang Siess
Blood 2004 103: 2435-2436.
[Full Text]
[PDF]
-
Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase
- Stepan Gambaryan, Jörg Geiger, Ulrike R. Schwarz, Elke Butt, Antonija Begonja, Achim Obergfell, and Ulrich Walter
Blood 2004 103: 2593-2600.
[Abstract]
[Full Text]
[PDF]
Related Letter in Blood Online:
-
On the roles of cGMP and glycoprotein Ib in platelet activation
- Xiaoping Du, Jasna A. Marjanovic, Zhenyu Li, Yotis Senis, Stuart Marshall, and Steve Watson
Blood 2004 103: 4371-4372.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
N. Valtcheva, P. Nestorov, A. Beck, M. Russwurm, M. Hillenbrand, P. Weinmeister, and R. Feil
The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells
J. Biol. Chem.,
January 2, 2009;
284(1):
556 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kauskot, F. Adam, A. Mazharian, N. Ajzenberg, E. Berrou, A. Bonnefoy, J.-P. Rosa, M. F. Hoylaerts, and M. Bryckaert
Involvement of the Mitogen-activated Protein Kinase c-Jun NH2-terminal Kinase 1 in Thrombus Formation
J. Biol. Chem.,
November 2, 2007;
282(44):
31990 - 31999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Bilodeau and H. E. Hamm
Regulation of Protease-Activated Receptor (PAR) 1 and PAR4 Signaling in Human Platelets by Compartmentalized Cyclic Nucleotide Actions
J. Pharmacol. Exp. Ther.,
August 1, 2007;
322(2):
778 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Senis, M. G. Tomlinson, A. Garcia, S. Dumon, V. L. Heath, J. Herbert, S. P. Cobbold, J. C. Spalton, S. Ayman, R. Antrobus, et al.
A Comprehensive Proteomics and Genomics Analysis Reveals Novel Transmembrane Proteins in Human Platelets and Mouse Megakaryocytes Including G6b-B, a Novel Immunoreceptor Tyrosine-based Inhibitory Motif Protein
Mol. Cell. Proteomics,
March 1, 2007;
6(3):
548 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mazharian, S. Roger, E. Berrou, F. Adam, A. Kauskot, P. Nurden, M. Jandrot-Perrus, and M. Bryckaert
Protease-activating Receptor-4 Induces Full Platelet Spreading on a Fibrinogen Matrix: INVOLVEMENT OF ERK2 AND p38 AND Ca2+ MOBILIZATION
J. Biol. Chem.,
February 23, 2007;
282(8):
5478 - 5487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Antl, M.-L. von Bruhl, C. Eiglsperger, M. Werner, I. Konrad, T. Kocher, M. Wilm, F. Hofmann, S. Massberg, and J. Schlossmann
IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation
Blood,
January 15, 2007;
109(2):
552 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Begonja, J. Geiger, N. Rukoyatkina, S. Rauchfuss, S. Gambaryan, and U. Walter
Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase
Blood,
January 15, 2007;
109(2):
616 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, M. E. Fitzgerald, M. C. Berndt, C. W. Jackson, and T. K. Gartner
Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo
Blood,
October 15, 2006;
108(8):
2596 - 2603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stojanovic, J. A. Marjanovic, V. M. Brovkovych, X. Peng, N. Hay, R. A. Skidgel, and X. Du
A Phosphoinositide 3-Kinase-AKT-Nitric Oxide-cGMP Signaling Pathway in Stimulating Platelet Secretion and Aggregation
J. Biol. Chem.,
June 16, 2006;
281(24):
16333 - 16339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. McGettrick, J. M. Lord, K.-Q. Wang, G. E. Rainger, C. D. Buckley, and G. B. Nash
Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium
J. Leukoc. Biol.,
April 1, 2006;
79(4):
779 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann
Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion
Physiol Rev,
January 1, 2006;
86(1):
1 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garcia, T. M. Quinton, R. T. Dorsam, and S. P. Kunapuli
Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets
Blood,
November 15, 2005;
106(10):
3410 - 3414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Marjanovic, Z. Li, A. Stojanovic, and X. Du
Stimulatory Roles of Nitric-oxide Synthase 3 and Guanylyl Cyclase in Platelet Activation
J. Biol. Chem.,
November 11, 2005;
280(45):
37430 - 37438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mazharian, S. Roger, P. Maurice, E. Berrou, M. R. Popoff, M. F. Hoylaerts, F. Fauvel-Lafeve, A. Bonnefoy, and M. Bryckaert
Differential Involvement of ERK2 and p38 in Platelet Adhesion to Collagen
J. Biol. Chem.,
July 15, 2005;
280(28):
26002 - 26010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hofmann
The Biology of Cyclic GMP-dependent Protein Kinases
J. Biol. Chem.,
January 7, 2005;
280(1):
1 - 4.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mazzucato, M. R. Cozzi, P. Pradella, Z. M. Ruggeri, and L. De Marco
Distinct roles of ADP receptors in von Willebrand factor-mediated platelet signaling and activation under high flow
Blood,
November 15, 2004;
104(10):
3221 - 3227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Walter and S. Gambaryan
Roles of cGMP/cGMP-dependent protein kinase in platelet activation
Blood,
October 15, 2004;
104(8):
2609 - 2609.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-A. Yang, C. L. Carpenter, and C. S. Abrams
Rho and Rho-kinase Mediate Thrombin-induced Phosphatidylinositol 4-Phosphate 5-Kinase Trafficking in Platelets
J. Biol. Chem.,
October 1, 2004;
279(40):
42331 - 42336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Thottassery, Y. Sun, L. Westbrook, S. S. Rentz, M. Manuvakhova, Z. Qu, S. Samuel, R. Upshaw, A. Cunningham, and F. G. Kern
Prolonged Extracellular Signal-Regulated Kinase 1/2 Activation during Fibroblast Growth Factor 1- or Heregulin {beta}1-Induced Antiestrogen-Resistant Growth of Breast Cancer Cells Is Resistant to Mitogen-Activated Protein/Extracellular Regulated Kinase Kinase Inhibitors
Cancer Res.,
July 1, 2004;
64(13):
4637 - 4647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Du, J. A. Marjanovic, Z. Li, Y. Senis, S. Marshall, and S. Watson
On the roles of cGMP and glycoprotein Ib in platelet activation
Blood,
June 1, 2004;
103(11):
4371 - 4372.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gambaryan, J. Geiger, U. R. Schwarz, E. Butt, A. Begonja, A. Obergfell, and U. Walter
Potent inhibition of human platelets by cGMP analogs independent of cGMP-dependent protein kinase
Blood,
April 1, 2004;
103(7):
2593 - 2600.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|